With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! There’s new information about vaccines daily but it can be challenging to keep up. Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss vaccines for children 5-11 years old, and vaccine-associated Myocarditis.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss trends in substance use throughout the pandemic and common clinical questions about thrombosis and antithrombotic therapy in patients with SARS-CoV-2 infection.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how the post-acute sequalae of COVID-19 (PASC) and trends, prevention, and treatment of COVID-19 infection among children and young people.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how seropositivity levels can vary after vaccination and which patients would make good candidates for monoclonal antibodies (mAbs). You’ll also hear the latest clinical trials data on the efficacy of mAbs.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the use of the COVID-19 vaccine in two important patient populations: adolescents and pregnant women. You’ll also hear the latest guidance on when to wear a mask.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the incidence and clinical features of vaccine-induced thrombotic thrombocytopenia (VITT) and the epidemiology and treatment of emerging COVID-19 variants.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the adoption of and barriers to telemedicine in the COVID-19 pandemic and examine the emerging data on ivermectin and fluvoxamine for the treatment of patients with COVID-19.

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the most common reactions to the two approved COVID-19 mRNA vaccines, as well as evaluate the data on the efficacy of zinc and vitamin C on outpatients and single high dose of vitamin D among inpatients with SARS-CoV-2 infection.

In the twenty-fifth episode of Pri-Med’s web series on COVID-19, faculty will approach the emerging and concerning concept of “long-haul” COVID-19. Additionally, this session will discuss postural orthostatic tachycardia syndrome (POTS) and the mechanisms connecting SARS-CoV-2 infection to POTS. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 02/09/2021 and they are subject to change as new information is published.

Join us for the first COVID-19 Pulse session of 2021! In the twenty-fourth episode of Pri-Med’s web series on COVID-19, faculty will walk through the Advisory Committee on Immunization Practices (ACIP) guidelines for COVID-19 vaccine prioritization as well as the newest data on these vaccines. This session will discuss the emerging SARS-CoV-2 variants and their potential implications. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.

In the fourteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the recent data on COVID-19 and children. This presentation will cover the typical presentation of COVID-19 in children and review the risk and mechanisms of Multisystem Inflammatory Syndrome in Children (MIS-C).